TRV GP III, LLC - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
TRV GP III, LLC ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,688,000
-22.8%
1,148,7800.0%1.17%
-17.6%
Q2 2022$3,481,000
-55.4%
1,148,7800.0%1.42%
-32.7%
Q1 2022$7,800,000
-18.7%
1,148,7800.0%2.12%
-11.8%
Q4 2021$9,592,000
-57.7%
1,148,780
-62.3%
2.40%
-44.2%
Q3 2021$22,652,000
+9.3%
3,048,7800.0%4.30%
+18.8%
Q2 2021$20,732,000
-33.8%
3,048,7800.0%3.62%
-8.6%
Q1 2021$31,311,000
+46.7%
3,048,7800.0%3.96%
+116.1%
Q4 2020$21,342,000
-14.2%
3,048,7800.0%1.83%
-12.3%
Q3 2020$24,878,000
+18.3%
3,048,7800.0%2.09%
-31.9%
Q2 2020$21,037,000
+45.3%
3,048,7800.0%3.07%
-22.1%
Q1 2020$14,482,000
-45.6%
3,048,7800.0%3.94%
-66.5%
Q4 2019$26,616,000
+162.2%
3,048,7800.0%11.75%
+104.3%
Q3 2019$10,152,000
-32.7%
3,048,7800.0%5.75%
-10.3%
Q2 2019$15,091,000
-20.2%
3,048,7800.0%6.42%
-30.7%
Q1 2019$18,902,000
+84.0%
3,048,7800.0%9.26%
+7.6%
Q4 2018$10,274,000
-48.2%
3,048,7800.0%8.61%
-2.7%
Q3 2018$19,817,000
-15.1%
3,048,7800.0%8.85%
+13.8%
Q2 2018$23,354,000
-65.7%
3,048,7800.0%7.78%
-68.3%
Q1 2018$68,140,000
+75.3%
3,048,7800.0%24.53%
+80.2%
Q4 2017$38,872,0003,048,78013.61%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders